Changes in vascular smooth muscle reactivity during development.
D000313:Adrenal Medulla / Q000294:innervation; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D002543:Cerebral Hemorrhage / Q000503:physiopathology; D004761:Enterocolitis, Pseudomembranous / Q000503:physiopathology; D006321:Heart / Q000294:innervation; D006801:Humans; D007231:Infant, Newborn; D009119:Muscle Contraction / Q000187:drug effects; D024510:Muscle Development; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000254:growth & development* / Q000294:innervation; D010275:Parasympathetic Nervous System / Q000502:physiology; D010547:Persistent Fetal Circulation Syndrome / Q000503:physiopathology; D013045:Species Specificity
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists